Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03049800 · ClinicalTrials.gov registry record
Is Cognitive Training Neuroprotective in Early Psychosis?
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 36
- Enrollment target
NCT03049800 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 36 participants.
The verdict
NCT03049800 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to perform longitudinal high-resolution 7T MRI and Prisma 3T MRI in participants with first-episode psychosis (FEP) enrolled in our ongoing randomized controlled clinical trial (RCT) of cognitive training. The investigators seek to determine whether a 12-week course of intensive cognitive training of auditory processing in young FEP patients delivered remotely as a stand-alone treatment is neuroprotective against neural tissue loss in auditory cortex (superior temporal gyrus, STG), and possibly in other cortical regions. The investigators will also observe the effects of training on white matter integrity in the brain.
Interventions
- DEVICE Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2021-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03049800
The ClinicalTrials.gov registry entry for NCT03049800 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging is the first listed.
NCT03049800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03049800 about?
NCT03049800 is a clinical study titled "Is Cognitive Training Neuroprotective in Early Psychosis?". The purpose of this study is to perform longitudinal high-resolution 7T MRI and Prisma 3T MRI in participants with first-episode psychosis (FEP) enrolled in our ongoing randomized controlled clinical trial (RCT) of cognitive training. The investigators seek to determine whether a 12-week course of i...
What is the current status of trial NCT03049800?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2017-06-12. Estimated completion is 2021-02-15.
What interventions are being tested in trial NCT03049800?
The interventions under investigation include: Magnetic Resonance Imaging (DEVICE).
Who is sponsoring clinical trial NCT03049800?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.